C
Crinetics Pharmaceuticals
Biotech & Life Sciences · San Diego, United States · Founded 2008 · IPO 2018
Novel therapeutics targeting peptide hormone receptors for the treatment of endocrine-related diseases and cancers MoreLess
Crinetics Pharmaceuticals is a clinical-stage pharmaceutical company specializing in the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. The company operates in the biopharmaceutical market, targeting conditions that have limited treatment options. Crinetics serves patients with rare endocrine disorders, such as acromegaly, by developing innovative oral treatments like CRN00808, which is currently in Phase 2 clinical trials. The business model focuses on advancing drug candidates through clinical trials and obtaining regulatory approvals to bring these therapies to market. Revenue is generated through the commercialization of approved drugs and potential partnerships or licensing agreements with larger pharmaceutical companies.
Keywords: endocrine diseases, rare disorders, novel therapeutics, clinical trials, drug discovery, acromegaly, oral treatments, biopharmaceutical, GPCRs, commercialization.
Talent graph
Crinetics Pharmaceuticals's talent
Source: Dealroom Talent Intelligence.
Investors
20 investors on Crinetics Pharmaceuticals's cap table
Sourced from Dealroom's funding history. Investor profile links are shown where available.
Global footprint
Where Crinetics Pharmaceuticals has talent and traffic
team presence
across markets
Patent intelligence
$79M patent portfolio · 46 active families
Where Crinetics Pharmaceuticals concentrates vs peers
Each axis is a top-10 topic across Crinetics Pharmaceuticals and its closest peers. #1 = 100, #10 = 10, absent = 0.
Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.
Market sentiment
What the market is saying about Crinetics Pharmaceuticals
An AI-synthesized read of the highest-engagement posts about Crinetics Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Crinetics Pharmaceuticals on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.